Promotion of Knee Cartilage Degradation by IκB Kinase ε in the Pathogenesis of Osteoarthritis in Human and Murine Models
Promotion of Knee Cartilage Degradation by IκB Kinase ε in the Pathogenesis of Osteoarthritis in Human and Murine Models
复制标题
IκB 激酶 ε 在人类和小鼠模型骨关节炎发病机制中促进膝关节软骨降解
DOI:
10.1002/art.42421
复制
发表时间:
2023
影响因子:
13.3
通讯作者:
Nakashima Yasuharu
中科院分区:
文献类型:
--
作者:
Uchida Taisuke;Akasaki Yukio;Sueishi Takuya;Kurakazu Ichiro;Toya Masakazu;Kuwahara Masanari;Hirose Ryota;Hyodo Yuki;Tsushima Hidetoshi;Lotz Martin K.;Nakashima Yasuharu
ObjectiveNF‐κB signaling is an important modulator in osteoarthritis (OA), and IκB kinase ε (IKKε) regulates the NF‐κB pathway. This study was undertaken to identify the functional involvement of IKKε in the pathogenesis of OA and the effectiveness of IKKε inhibition as a modulatory treatment.MethodsIKKε expression in normal and OA human knee joints was analyzed immunohistochemically. Gain‐ or loss‐of‐function experiments were performed using human chondrocytes. Furthermore, OA was surgically induced in mice, followed by intraarticular injection of BAY‐985, an IKKε/TANK‐binding kinase 1 inhibitor, into the left knee joint every 5 days for 8 weeks. Mice were subsequently examined for histologic features of cartilage damage and inflammation.ResultsIKKε protein expression was increased in human OA cartilage. In vitro, expression levels of OA‐related factors were down‐regulated following knockdown of IKKε with the use of small interfering RNA in human OA chondrocytes or following treatment with BAY‐985. Conversely, IKKε overexpression significantly increased the expression of OA‐related catabolic mediators. In Western blot analysis of human chondrocytes, IKKε overexpression increased the phosphorylation of IκBα and p65. In vivo, intraarticular injection of BAY‐985 into the knee joints of mice attenuated OA‐related cartilage degradation and hyperalgesia via NF‐κB signaling.ConclusionThese results suggest that IKKε regulates cartilage degradation through a catabolic response mediated by NF‐κB signaling, and this could represent a potential target for OA treatment. Furthermore, BAY‐985 may serve as a major disease‐modifying compound among the drugs developed for OA.
登录
查看更多内容
影响因子:
3.3
作者:
L;W. Zeng;Lin Sun;Y. Wang;F. Jiang;X. Li;Y. Zheng;G. Wu
通讯作者:
G. Wu
影响因子:
--
作者:
Péant B;Gilbert S;Le Page C;Poisson A;L'Ecuyer E;Boudhraa Z;Bienz MN;Delvoye N;Saad F;Mes-Masson AM
通讯作者:
Mes-Masson AM
影响因子:
7
作者:
Kurakazu I;Akasaki Y;Tsushima H;Sueishi T;Toya M;Kuwahara M;Uchida T;Lotz MK;Nakashima Y
通讯作者:
Nakashima Y
DOI:
--
发表时间:
2000
期刊:
影响因子:
--
作者:
D. Rudolph;W. Yeh;A. Wakeham;B. Rudolph;D. Nallainathan;J. Potter;A. Elia;T. Mak
通讯作者:
T. Mak
影响因子:
--
作者:
Little, C. B.;Barai, A.;Burkhardt, D.;Smith, S. M.;Fosang, A. J.;Werb, Z.;Shah, M.;Thompson, E. W.
通讯作者:
Thompson, E. W.